Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer.

Medical oncology (Northwood, London, England) - 1 Oct 2014

Ying Hongyan, Yang Xian-Da, Sun Zhao, Ning Xiaohong, Wang Yingyi, Bai Chunmai, Chen Shuchang, Wang Yuzhou

Abstract excerpt

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have been shown to improve the prognosis of EGFR-mutated (exon 19/21) non-small cell lung carcinoma (NSCLC). Positive EGFR mutation status is associated with NSCLC in non-smokers. Genetic and environmental factors have been linked to the etiology of EGFR mutations and sensitivity to EGFR-TKIs in non-smoking NSCLC patients. Cooking fume...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asia, Southeastern
Share to Cooking

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erlotinib Hydrochloride

Share to Gefitinib

Share to Genes, erbB-1

Share to Inhalation Exposure

Share to Life Style

Share to Quinazolines

Source

Identifiers

PMID: 25216867
DOI: 10.1007/s12032-014-0220-4

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer.PMID 25216867Read ↗

Cigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMT.Semantic proximity Read ↗

Clinical aspects of epidermal growth factor receptor inhibitors: benefit and risk.Semantic proximity Read ↗

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment.Semantic proximity Read ↗

Interaction between Polymorphisms in Pre-MiRNA Genes and Cooking Oil Fume Exposure on the Risk of Lung Cancer in Chinese Non-Smoking Female Population.Semantic proximity Read ↗

Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.Semantic proximity Read ↗

Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation.Semantic proximity Read ↗

Combined effects of lung disease history, environmental exposures, and family history of lung cancer to susceptibility of lung cancer in Chinese non-smokers.Semantic proximity Read ↗

Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.Semantic proximity Read ↗

Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.Semantic proximity Read ↗

Association between lung cancer somatic mutations and occupational exposure in never-smokers.Semantic proximity Read ↗

Impact of occupational carcinogens on lung cancer risk in a general populationSemantic proximity Read ↗

Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.